Sirius Medical funding news – Eindhoven-based Sirius Medical Raises €10Million in Additional Scale-up Funding

This investment round was led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and Sirius Medical’s team.

World Cancer Day is a poignant reminder of the ongoing fight against cancer, and this milestone reflects it’s commitment to enhancing cancer care. Praised by breast cancer surgeons worldwide, the Sirius Pintuition® surgical navigation platform enables simple, best-in-class wire-free localization for breast-conserving surgery in any hospital.

Read also - Wingbits Funding News- Sweden- based Wingbits Raises €5.3Mn to Transform Flight Tracking

This latest funding round empowers it to enhance the Sirius Pintuition system and GPSDetect™ software platform, focusing on usability and intuitiveness, and extending its applications. Additionally, the investment will substantially bolster the sales infrastructure and support expansion into new markets.

Karin Steffens, senior investment manager at Invest-NL said, “At Invest-NL our healthcare focus is on investing in innovations that aim to avoid, replace, or relocate expensive care, Sirius Medical’s mission to develop sustainable technology solutions while maintaining balance within the healthcare system closely aligns with our mission to accelerate the healthcare transition. We are excited to back a company making such a meaningful difference for women with breast cancer."

Bram Schermers, CEO of Sirius Medical said, “Announcing this funding milestone on World Cancer Day underscores the urgency of our mission to improve cancer care globally, This funding round, in the current fundraising environment, is a clear testament to the talent of the Sirius Medical team, and the Pintuition technology that we have developed. We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical. We will have more exciting news to announce soon.”

Roel Dekkers, Investment Manager, NextGen Ventures said, “The Sirius Medical leadership team has shown exceptional expertise and adaptability, The company is well positioned for expansion and we see a tremendous opportunity for growth in untapped markets."

About Sirius Medical

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. Sirius Pintuition is precise, simple, affordable and both CE marked, and FDA cleared. It is rapidly expanding with over 250 centers and 35.000 procedures globally,